Researchers at Politecnico di Torino have developed new energy storage technology that could help tackle two major global challenges: reducing industrial carbon emissions and boosting renewable energy efficiency.
Researchers from the University of North Carolina and NC State have developed artificial beta cells that automatically release insulin into the bloodstream when glucose levels rise, leading the way for new diabetes treatment.
Dr Carlos Ziebert, Head of IAM-AWP’s Calorimeter Center, KIT, presents a holistic approach to how battery calorimeters can be applied all along the battery value chain.
Megan Warrender of Open Access Government explores Department for Business, Energy, and Industrial Strategy, led by Rt Hon Alok Sharma MP’s, priorities for energy policy in response to COVID-19.
Here, we learn how about a different kind of green crop that grows in Ireland and the journey of that from seed to shelf as part of the Greenheart CBD story.
Manager EU Research at Centexbel, Guy Buyle introduces REMADYL, a H2020 project focused on the removal of legacy substances from PVC via a continuous and sustainable extrusion process.
The strides being made by the European Commission to achieve a digitalised society for all are explored by Assistant Editor of Open Access Government, Megan Warrender.
Vernon Hunte, Associate Director of Public Affairs at April Six, discusses how COVID-19 will change up out attitude towards artificial intelligence (AI) ethics.
In the first of two articles, the US member firm of Ius Laboris, provides suggestions on actions employers in the United States should reinforce against racism and discrimination in the workplace.
Lee Hatwell, director of Munday + Cramer, addresses some of the most frequently asked questions regarding what simple measures can be taken to meet new Government safety standards and ease employee anxieties towards returning to work.
Sue Johnson Gregory, principal consultant, and Tim Powlson, senior consultant, at Entec Si, discuss how the NHS can recover from the long-term impact of COVID-19.
In the last six months GreenLight Medicines has successfully out-licenced leads from its research, branching out internationally and attracting major investors.
In this interview, David Engel from Full Moon Investments in the U.S., charts the firm’s successful targeted investment strategy – informed by industry-leading experience and expertise – including comments on the CBD hemp and medical cannabis space.
Here, we highlight how parents can continue to encourage children into STEM (Science, technology, engineering, and mathematics) subjects during lockdown and beyond.
